Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Tilley

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Human Genetics|June 1, 1990
The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive historyG P Nowinski, D L Van Dyke, B C Tilley, et al.
The New England Journal of Medicine|March 13, 1980
Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrolA B Barnes, T Colton, J Gundersen, et al.
Preventive Medicine|March 1, 1997
Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step TrialB C Tilley, S W Vernon, K Glanz, et al.
Neurology|March 15, 2006
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designsB C Tilley, Y Y Palesch, K Kieburtz, et al.
Annals of Surgery|October 1, 1988
Recurrent femoral anastomotic aneurysms. A 30-year experienceC B Ernst, J P Elliott, C J Ryan, et al.
Genes, Chromosomes & Cancer|March 1, 1994
Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck regionD L Van Dyke, M J Worsham, M S Benninger, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|August 26, 1998
Hypertension and its treatment in the NINDS rt-PA Stroke TrialT Brott, M Lu, R Kothari, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Human Genetics|June 1, 1990
The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive historyG P Nowinski, D L Van Dyke, B C Tilley, et al.
The New England Journal of Medicine|March 13, 1980
Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrolA B Barnes, T Colton, J Gundersen, et al.
Preventive Medicine|March 1, 1997
Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step TrialB C Tilley, S W Vernon, K Glanz, et al.
Neurology|March 15, 2006
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designsB C Tilley, Y Y Palesch, K Kieburtz, et al.
Annals of Surgery|October 1, 1988
Recurrent femoral anastomotic aneurysms. A 30-year experienceC B Ernst, J P Elliott, C J Ryan, et al.
Genes, Chromosomes & Cancer|March 1, 1994
Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck regionD L Van Dyke, M J Worsham, M S Benninger, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
Stroke|August 26, 1998
Hypertension and its treatment in the NINDS rt-PA Stroke TrialT Brott, M Lu, R Kothari, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Pageof 7